You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Co-Diagnostics will license its CoPrimers technology to Biosearch to make, use, market, and sell the primer-dimer-reducing oligonucleotides.
The sensitivity of real-time PCR-based testing of dried blood spots is too low to use the method as a routine test for CMV infection in newborns. Despite this, PCR testing of other bodily fluids such as saliva still holds promise for such a test.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.